Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
Legal advocacy addresses patients’ health-harming legal needs in housing, public benefits, employment, education, immigration, domestic violence, and other areas of law.
Prashasti Bhatnagar joins Ethics Talk to discuss her article, coauthored with Dr Deborah F. Perry and Margaret E. Greer: “How Should We Measure Effectiveness of Medical-Legal Partnerships?”
A case exploring who has the authority to make contraceptive choices, 15-year-old girl whose sexually active status is unknown or her mother, and what is the physician's duty in the situation.